Biopharmaceutical NewsWeek 47   Acquisitions /Mergers/Joint-ventures November 17, 2014  Actavis officially acquires Allergan with $66B buyout Actavis has agreed propose $219 per share, in cash and stock, for the acquisition of Allergan. That makes the deal worth about $66 billion, based on Actavis' closing price Friday. And it's a price Valeant CEO J. Michael Pearson […]

Biopharmaceutical NewsWeek 46        Acquisitions /Mergers/Joint-ventures November 12, 2014  Actavis in talks with Allergan for $60 billion merger According to a Bloomberg report, Actavis would acquire Allergan for $60 billion. Allergan has spent the past few months in trying to avoid the hostile take-over by Valeant.   Business November 6, 2014  Aegerion acquires […]

  Thank you for our meeting at Biofit     – PowerPoint Presentation Btobioinnovation – Résumé – Flyer-Btobioinnovation – How we could work Together- prospection by phone & e-mail